This issue of the ECDC Communicable Disease Threats Report (CDTR) covers the period 7 - 13 April 2024 and includes updates on measles, avian influenza, COVID-19, Mpox, seasonal influenza, RSV, cholera and shigellosis.
Annual Declarations of Interest and Declarations of Commitment from the Director, Heads of Unit, and members of ECDC's governance bodies are published online to ensure that they do not have a personal interest that could impair their independence.
Significant disruptions were observed in HIV-specific services, particularly for in-clinic and community-based HIV testing, according to the ECDC report "The impact of the COVID-19 pandemic on the HIV response in Europe and Central Asia."
This report provides a record of the impact noted by countries on HIV services and monitoring capacity which can be used retrospectively to better understand the effects of the COVID-19 pandemic on the HIV situation in the European Region.
Public health institutes across Europe increasingly recognise the value of examining public health trends and imagining what the future may look like according to different scenarios.
This report presents pooled COVID-19 vaccine effectiveness (VE) estimates for the first, second and third booster doses (compared to complete primary vaccination with no booster) against hospitalisation due to COVID-19 and COVID-19-related death in resident populations ≥50 years of age living in the community.